Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study.

Chitty LS, Finning K, Wade A, Soothill P, Martin B, Oxenford K, Daniels G, Massey E.

BMJ. 2014 Sep 4;349:g5243. doi: 10.1136/bmj.g5243.

2.

Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS.

Soothill PW, Finning K, Latham T, Wreford-Bush T, Ford J, Daniels G.

BJOG. 2015 Nov;122(12):1682-6. doi: 10.1111/1471-0528.13055. Epub 2014 Aug 21.

3.

The role of VEGF-A165b in trophoblast survival.

Bills VL, Hamdollah-Zadeh M, Soothill PW, Harper SJ, Bates DO.

BMC Pregnancy Childbirth. 2014 Aug 15;14:278. doi: 10.1186/1471-2393-14-278.

4.

Fetal blood grouping using cell free DNA - an improved service for RhD negative pregnant women.

Bills VL, Soothill PW.

Transfus Apher Sci. 2014 Apr;50(2):148-53. doi: 10.1016/j.transci.2014.02.005. Epub 2014 Mar 7. Review.

PMID:
24679596
5.

Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.

Kent J, Farrell AM, Soothill P.

BMC Pregnancy Childbirth. 2014 Feb 25;14:87. doi: 10.1186/1471-2393-14-87. Review.

6.

Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion: a service evaluation.

Birchenall KA, Illanes SE, Lopez F, Overton T, Liebling R, Soothill PW, Abdel-Fattah S, Denbow M.

Blood Transfus. 2013 Oct;11(4):548-52. doi: 10.2450/2013.0288-12. Epub 2013 Jul 19.

7.

First trimester prediction of early onset preeclampsia using demographic, clinical, and sonographic data: a cohort study.

Caradeux J, Serra R, Nien JK, Pérez-Sepulveda A, Schepeler M, Guerra F, Gutiérrez J, Martínez J, Cabrera C, Figueroa-Diesel H, Soothill P, Illanes SE.

Prenat Diagn. 2013 Aug;33(8):732-6. doi: 10.1002/pd.4113. Epub 2013 May 3.

PMID:
23584890
8.

Quantification of free fetal DNA in multiple pregnancies and relationship with chorionicity.

Attilakos G, Maddocks DG, Davies T, Hunt LP, Avent ND, Soothill PW, Grant SR.

Prenat Diagn. 2011 Oct;31(10):967-72. doi: 10.1002/pd.2814. Epub 2011 Jul 19.

PMID:
21769896
9.

Impaired vascular permeability regulation caused by the VEGF₁₆₅b splice variant in pre-eclampsia.

Bills VL, Salmon AH, Harper SJ, Overton TG, Neal CR, Jeffery B, Soothill PW, Bates DO.

BJOG. 2011 Sep;118(10):1253-61. doi: 10.1111/j.1471-0528.2011.02925.x. Epub 2011 Jun 14.

10.

Antenatal interventions for fetomaternal alloimmune thrombocytopenia.

Rayment R, Brunskill SJ, Soothill PW, Roberts DJ, Bussel JB, Murphy MF.

Cochrane Database Syst Rev. 2011 May 11;(5):CD004226. doi: 10.1002/14651858.CD004226.pub3. Review.

PMID:
21563140
11.

Pseudotail as a feature of microphthalmia with linear skin defects syndrome.

Alberry MS, Juvanic G, Crolla J, Soothill P, Newbury-Ecob R.

Clin Dysmorphol. 2011 Apr;20(2):111-3. doi: 10.1097/MCD.0b013e328342eb66. No abstract available.

PMID:
21200317
12.

Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?

Cetin I, Huppertz B, Burton G, Cuckle H, Gonen R, Lapaire O, Mandia L, Nicolaides K, Redman C, Soothill P, Spencer K, Thilaganathan B, Williams D, Meiri H.

Placenta. 2011 Feb;32 Suppl:S4-16. doi: 10.1016/j.placenta.2010.11.022. Epub 2010 Dec 23.

PMID:
21185077
13.

Noninvasive approach for the management of hemolytic disease of the fetus.

Illanes S, Soothill P.

Expert Rev Hematol. 2009 Oct;2(5):577-82. doi: 10.1586/ehm.09.45. Review.

PMID:
21083022
14.

Management of red cell alloimmunisation in pregnancy: the non-invasive monitoring of the disease.

Illanes S, Soothill P.

Prenat Diagn. 2010 Jul;30(7):668-73. doi: 10.1002/pd.2551. Review.

PMID:
20572110
15.

Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.

Illanes S, Parra M, Serra R, Pino K, Figueroa-Diesel H, Romero C, Arraztoa JA, Michea L, Soothill PW.

Prenat Diagn. 2009 Dec;29(12):1118-22. doi: 10.1002/pd.2372.

PMID:
19816882
16.

Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit.

Simms RA, Liebling RE, Patel RR, Denbow ML, Abdel-Fattah SA, Soothill PW, Overton TG.

Fetal Diagn Ther. 2009;25(4):373-8. doi: 10.1159/000236149. Epub 2009 Sep 30.

PMID:
19786782
17.

Prognosis of spina bifida in the era of prenatal diagnosis and termination of pregnancy.

Aguilera S, Soothill P, Denbow M, Pople I.

Fetal Diagn Ther. 2009;26(2):68-74. doi: 10.1159/000238116. Epub 2009 Sep 11.

PMID:
19752521
18.

The SAFE project: towards non-invasive prenatal diagnosis.

Maddocks DG, Alberry MS, Attilakos G, Madgett TE, Choi K, Soothill PW, Avent ND.

Biochem Soc Trans. 2009 Apr;37(Pt 2):460-5. doi: 10.1042/BST0370460. Review.

PMID:
19290882
19.

Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications.

Avent ND, Madgett TE, Maddocks DG, Soothill PW.

Curr Opin Obstet Gynecol. 2009 Apr;21(2):175-9. doi: 10.1097/GCO.0b013e3283294798. Review.

PMID:
19262379
20.

Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.

Alberry MS, Maddocks DG, Hadi MA, Metawi H, Hunt LP, Abdel-Fattah SA, Avent ND, Soothill PW.

Am J Obstet Gynecol. 2009 Jan;200(1):98.e1-6. doi: 10.1016/j.ajog.2008.07.063.

PMID:
19121662
21.

Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.

Bills VL, Varet J, Millar A, Harper SJ, Soothill PW, Bates DO.

Clin Sci (Lond). 2009 Feb;116(3):265-72. doi: 10.1042/CS20080270. Erratum in: Clin Sci (Lond). 2009 Jul;116(12):873.

22.

Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy.

Kumpel BM, Sibley K, Jackson DJ, White G, Soothill PW.

Transfusion. 2008 Oct;48(10):2077-86. doi: 10.1111/j.1537-2995.2008.01832.x. Epub 2008 Jul 30.

PMID:
18673340
23.

Post-genomics studies and their application to non-invasive prenatal diagnosis.

Avent ND, Plummer ZE, Madgett TE, Maddocks DG, Soothill PW.

Semin Fetal Neonatal Med. 2008 Apr;13(2):91-8. doi: 10.1016/j.siny.2007.12.011. Epub 2008 Feb 4. Review.

PMID:
18249591
24.

Non-invasive prenatal diagnosis: implications for antenatal diagnosis and management of high-risk pregnancies.

Alberry MS, Soothill PW.

Semin Fetal Neonatal Med. 2008 Apr;13(2):84-90. doi: 10.1016/j.siny.2007.12.006. Epub 2008 Jan 30. Review.

PMID:
18249162
25.

PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction randomised controlled trial.

Pluto Collaborative Study Group, Kilby M, Khan K, Morris K, Daniels J, Gray R, Magill L, Martin B, Thompson P, Alfirevic Z, Kenny S, Bower S, Sturgiss S, Anumba D, Mason G, Tydeman G, Soothill P, Brackley K, Loughna P, Cameron A, Kumar S, Bullen P.

BJOG. 2007 Jul;114(7):904-5, e1-4.

26.

Allometric growth ratios are independent of Igf2 gene dosage during development.

Burns JL, Soothill P, Hassan AB.

Evol Dev. 2007 Mar-Apr;9(2):155-64.

PMID:
17371398
27.

Maternal serum transformed alpha-fetoprotein levels in women with intrauterine growth retardation.

Bartha JL, Illanes S, González-Bugatto F, Abdel-Fattah SA, Mizejewski GJ, Soothill PW.

Fetal Diagn Ther. 2007;22(4):294-8. Epub 2007 Mar 15.

PMID:
17361083
28.

Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast.

Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, Soothill PW.

Prenat Diagn. 2007 May;27(5):415-8.

PMID:
17286310
29.

Early detection of cell-free fetal DNA in maternal plasma.

Illanes S, Denbow M, Kailasam C, Finning K, Soothill PW.

Early Hum Dev. 2007 Sep;83(9):563-6. Epub 2007 Jan 16.

PMID:
17234369
30.

Management of fetal growth restriction.

Alberry M, Soothill P.

Arch Dis Child Fetal Neonatal Ed. 2007 Jan;92(1):F62-7. Review.

31.

Detection of cell-free fetal DNA in maternal urine.

Illanes S, Denbow ML, Smith RP, Overton TG, Soothill PW, Finning K.

Prenat Diagn. 2006 Dec;26(13):1216-8.

PMID:
17139694
32.

The obstetrician's view: ethical and societal implications of non-invasive prenatal diagnosis.

Smith RP, Lombaard H, Soothill PW.

Prenat Diagn. 2006 Jul;26(7):631-4. Review.

PMID:
16856227
33.

Pregnancy outcomes in women with or without placental malaria infection.

Kassam SN, Nesbitt S, Hunt LP, Oster N, Soothill P, Sergi C.

Int J Gynaecol Obstet. 2006 Jun;93(3):225-32. Epub 2006 Apr 13.

PMID:
16626713
34.

Maternal serum alpha-fetoprotein, fetal middle cerebral artery blood flow velocity and fetal haemoglobin in pregnancies at risk of fetal anaemia.

Bartha JL, Illanes S, Abdel-Fattah SA, Harrison G, Soothill PW.

Prenat Diagn. 2006 Feb;26(2):101-4.

PMID:
16463288
35.

The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term.

Bates DO, MacMillan PP, Manjaly JG, Qiu Y, Hudson SJ, Bevan HS, Hunter AJ, Soothill PW, Read M, Donaldson LF, Harper SJ.

Clin Sci (Lond). 2006 May;110(5):575-85.

PMID:
16451124
36.

Optimal interval between middle cerebral artery velocity measurements when monitoring pregnancies complicated by red cell alloimmunization.

Bartha JL, Abdel-Fattah SA, Hunter A, Denbow M, Kyle P, Soothill PW.

Fetal Diagn Ther. 2006;21(1):22-5.

PMID:
16354970
37.

Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism.

Jackson DJ, Murphy MF, Soothill PW, Lucas GF, Elson CJ, Kumpel BM.

Clin Exp Immunol. 2005 Oct;142(1):92-102.

38.

Is zygosity or chorionicity the main determinant of fetal outcome in twin pregnancies?

Carroll SG, Tyfield L, Reeve L, Porter H, Soothill P, Kyle PM.

Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):757-61.

PMID:
16150271
39.

Plasma atrial natriuretic peptide in fetuses with cardiac disease.

Bartha JL, Penney MD, Soothill PW.

Fetal Diagn Ther. 2005 Sep-Oct;20(5):426-30.

PMID:
16113566
40.

Reassuring fetal middle cerebral artery doppler velocimetry in alloimmunised pregnancies: neonatal outcomes without invasive procedures.

Abdel-Fattah SA, Shefras J, Kyle PM, Cairns P, Hunter A, Soothill PW.

Fetal Diagn Ther. 2005 Sep-Oct;20(5):341-5.

PMID:
16113550
41.

Prenatal diagnosis of echogenic lung: evolution and outcome.

Illanes S, Hunter A, Evans M, Cusick E, Soothill P.

Ultrasound Obstet Gynecol. 2005 Aug;26(2):145-9.

42.

Outcome of fetal pleural effusions treated by thoracoamniotic shunting.

Smith RP, Illanes S, Denbow ML, Soothill PW.

Ultrasound Obstet Gynecol. 2005 Jul;26(1):63-6.

43.

Plasma amyloid beta protein 1-42 levels in fetuses with Down syndrome.

Bartha JL, Soothill PW.

Early Hum Dev. 2005 Apr;81(4):351-4. Epub 2004 Oct 22.

PMID:
15814219
44.

Cell-free fetal DNA in maternal plasma: an important advance to link fetal genetics to obstetric ultrasound.

Illanes S, Avent N, Soothill PW.

Ultrasound Obstet Gynecol. 2005 Apr;25(4):317-22. Review. No abstract available.

45.

Clinical consequences of first-trimester growth discordance in twins.

Bartha JL, Ling Y, Kyle P, Soothill PW.

Eur J Obstet Gynecol Reprod Biol. 2005 Mar 1;119(1):56-9.

PMID:
15734085
46.

Comparison of different reference values of fetal blood flow velocity in the middle cerebral artery for predicting fetal anemia.

Bartha JL, Illanes S, Abdel-Fattah S, Hunter A, Denbow M, Soothill PW.

Ultrasound Obstet Gynecol. 2005 Apr;25(4):335-40.

47.

Management of fetal growth restriction.

Illanes S, Soothill P.

Semin Fetal Neonatal Med. 2004 Oct;9(5):395-401. Review.

PMID:
15691775
48.

Antenatal interventions for fetomaternal alloimmune thrombocytopenia.

Rayment R, Brunskill SJ, Stanworth S, Soothill PW, Roberts DJ, Murphy MF.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004226. Review. Update in: Cochrane Database Syst Rev. 2011;(5):CD004226.

PMID:
15674934
49.
50.

Responses to the 35% CO challenge in postpartum women.

Kaye J, Soothill P, Hunt M, Lightman S.

Clin Endocrinol (Oxf). 2004 Nov;61(5):582-8.

PMID:
15521960

Supplemental Content

Loading ...
Support Center